BlackRock Investment Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

BlackRock Investment Management’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-638	Closed	-$3K	–	4333
2015 Q1	$3K	Hold	638	–	–	﹤0.01%	3965
2014 Q4	$9K	Sell	638 -91	-12%	-$1.3K	﹤0.01%	3742
2014 Q3	$9K	Buy	729 +62	+9%	+$855	﹤0.01%	3742
2014 Q2	$12K	Sell	667 -3,856	-85%	-$66K	﹤0.01%	3590
2014 Q1	$98K	Buy	4,523 +634	+16%	+$18.4K	﹤0.01%	3300
2013 Q4	$138K	Buy	3,889 +920	+31%	+$30.8K	﹤0.01%	3255
2013 Q3	$107K	Buy	2,969 +235	+9%	+$10.7K	﹤0.01%	3232
2013 Q2	$124K	Buy	+2,734	New	+$124K	﹤0.01%	3209

Other funds holding KBIO

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock Investment Management's KBIO Position: Q2 2015 in Review

BlackRock Investment Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q2 2015, closing a stake of 638 shares — an estimated $3K sold.

BlackRock Investment Management first reported a position in KBIO in Q2 2013 and held it in 8 quarters. The position peaked at $138K in Q4 2013. 19 funds tracked by Wall St. Rank hold KBIO as of Q2 2015.

BlackRock Investment Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q2 2015 after selling out during the quarter.
BlackRock Investment Management sold 638 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q2 2015, an estimated $3K.
BlackRock Investment Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 8 quarters.
BlackRock Investment Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $138K in Q4 2013.
19 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.